Accelera Innovations Competitors and Similar CompaniesClear all

Accelera Innovations's competitors and similar companies include Metabolon, MedImpact, PolyPid and Adaptimmune.

	Accelera Innovations Accelera Innovations revolutionizes quality, cost and patient outcomes in the healthcare industry.	Metabolon Global leader in metabolomics for precision medicine, biomarker discovery, and advancing pharma & life sciences research.	MedImpact MedImpact, an independent, trend-focused PBM, is a privately held PBM, serving health plans, self-funded employers and government entities.	PolyPid PolyPid is a company developing a technology platform that enables a controlled and prolonged release of active pharmaceutical ingredients (API).	Adaptimmune Adaptimmune Limited develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases.
Founding Date	Founding Date 2008	Founding Date 2000	Founding Date 1989	Founding Date 2008	Founding Date 2008
Type	Type Public	Type Private	Type Private	Type Public	Type Public
Tags	Tags Healthcare Technology healthtech pharma	Tags Healthcare Technology biotech healthtech pharma	Tags Healthcare Technology app development healthtech pharma	Tags Healthcare Technology biotech healthtech pharma	Tags Healthcare Technology biotech healthtech pharma
Locations	Locations Frankfort, US HQ	Locations Morrisville, US HQ Hallbergmoos, DE München, DE	Locations San Diego, US HQ Beijing, CN Tempe, US Van Buren Charter Township, US	Locations Petah Tikva, IL HQ Summit, US	Locations Philadelphia, US HQ Milton, GB Milton, GB Stevenage, GB
Employees	Employees 4	Employees 1911% increase	Employees 1,8331% increase	Employees 57	Employees 4007% decrease
Valuation ($)	Valuation ($) 203.5 k	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 23.7 m	Valuation ($) 188.5 m
Financial
Revenue (est.)	Revenue (est.) $2.8k (FY, 2016)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $178m (FY, 2024)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A	Cost of goods $70k (FY, 2024)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit N/A	Gross profit N/A	Gross profit $178m (FY, 2024)
Net income	Net income ($1.9m) (FY, 2016)	Net income N/A	Net income N/A	Net income ($34.2m) (FY, 2025)	Net income ($70.8m) (FY, 2024)
Operating ⚠
Patent Applications	Patent Applications N/A	Patent Applications N/A	Patent Applications N/A	Patent Applications 49 (FY, 2017)	Patent Applications 69 (FY, 2016)
Patents Issued	Patents Issued N/A	Patents Issued N/A	Patents Issued N/A	Patents Issued 104 (FY, 2017)	Patents Issued 173 (FY, 2016)
Funding
Latest funding round	Latest funding round N/A	Latest funding round $ 15m (over 9 years ago)	Latest funding round $ 1.4m (over 12 years ago)	Latest funding round N/A	Latest funding round N/A
Total funding raised	Total funding raised N/A	Total funding raised $ 95.4m	Total funding raised $ 1.4m	Total funding raised $ 103.8m	Total funding raised $ 107.5m